Drug · DIN 01926691
CALCIMAR
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 10, 2026; first marketed December 31, 1983.
- Drug Identification Number (DIN)
- 01926691
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous; Intramuscular
- Therapeutic class (ATC)
- Calcitonin (salmon synthetic) H05BA01
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CALCITONIN (SALMON SYNTHETIC) | 200 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 18, 2006: NOC 7976New Drug Submission (NDS) · Manufacturer name change
- October 24, 2000: NOC 1470New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “calcimar”. A notice may cover another product or only some lots: read it to see what it covers.